Aims To explore whether a quantitative approach to identifying hospitalized patients with diabetes at risk of hypoglycaemia would be feasible through incorporation of routine biochemical, haematological and prescription data.
Introduction
Hospitalized patients with diabetes have high infection rates [1] [2] [3] [4] , longer hospital stay [5] [6] [7] and greater mortality (10% higher) [8] . Hypoglycaemia is one of the important determining events for this worse prognosis, which can be reflected in excess mortality, a longer hospital stay and more complications among patients with diabetes [9] [10] [11] . Predicting the risk of hypoglycaemia in hospitalized patients with diabetes mellitus and preventing its occurrence in a selected, high-risk subset of such patients through active monitoring or therapeutic modifications may therefore be an efficient way to improve outcomes.
A targeted and validated prediction model for identifying inpatients with diabetes who are at an increased risk of hypoglycaemia is still lacking, mainly because there is heterogeneity in populations, thresholds for hypoglycaemia, underlying diseases and comorbidities across relevant studies [11] [12] [13] [14] [15] [16] [17] [18] [19] . The Joint British Diabetes Societies, therefore, currently advocate a non-quantitative approach with regard to risk of inpatient hypoglycaemia in patients with diabetes [20] . Specifically, the recommended approach is to consider medical or lifestyle risk factors, such as strict glucose management, history of severe hypoglycaemic events, duration of insulin use, severe liver failure, renal failure, terminal illness or increasing age and alcohol use.
To explore whether a quantitative approach to identifying hospitalized patients with diabetes at risk of hypoglycaemia would be feasible and to construct a relevant prediction model incorporating routine biochemical data collected at admission, we performed a retrospective analysis of hospital admissions with diabetes.
Methods
All adult (age >16 years) patients with diabetes mellitus hospitalized in the general ward of our institution were considered as potentially eligible, irrespective of the primary diagnosis. The observation period was 1 January 2014 to 31 December 2014. The diagnosis of diabetes mellitus was consolidated by the presence of relevant Patient Administration System discharge codes for diabetes or the presence of a continuous anti-hyperglycaemic medication in the electronic medical record system, the Patient Information and Communication System. The diagnosis of diabetes was also ensured by cross-checking the Patient Administration System database for the International Classification of Diseases version 10 diabetes codes (E10-E14) retrospectively for the previous 10 years, up to 2004. Prescription of metformin or short-acting insulin in the absence of a diabetes code was considered an exclusion criterion to ensure case (diabetes mellitus) definition. Patients admitted to intensive therapy unit (ITU) were excluded from the analysis.
The outcome of interest was the occurrence of hypoglycaemia, which was defined as a blood glucose level of < 4 mmol/l (point of care or laboratory blood glucose measurement).
Statistical analysis
Baseline differences in continuous data between hypoglycaemic and non-hypoglycaemic groups were explored using Student's t-test or the Mann-Whitney U-test according to distribution. Differences in dichotomous data were explored using a chi-squared test.
The prediction model was constructed on the basis of a multivariable logistic regression model, with hypoglycaemia as the dependent outcome. This model was populated by clinically important variables, as identified by previous literature, including laboratory results as recorded in the Patient Information and Communication System. All variables with a P value at a significance level of 20% (P = 0.20) in the univariate analysis were included in the multivariable logistic regression model (Table S1 ). In cases where two variables were statistically significant but highly correlated, one was chosen based on clinical familiarity. Continuous data (e.g. age) were also analysed as categories to inspect potential non-linear effects. Areaunder-the-curve (AUC) analysis was performed to assess the predictive performance of the final model. A decision threshold was selected in order to maximize both sensitivity and specificity. Positive and negative predictive values were calculated using the prevalence of hypoglycaemia in this dataset. 
What's new?
• Hypoglycaemia is associated with worse outcomes in inpatients with diabetes. At present there is no targeted and validated prediction model in the UK for identifying those patients with an increased risk of hypoglycaemia.
• We performed a retrospective analysis of inpatient admissions with diabetes to develop a prediction model for hypoglycaemia incorporating routinely collected biochemical data.
• We found that the occurrence of hypoglycaemia could be predicted by a model incorporating background medication, ethnicity, age, admission type and laboratory measurements.
• Model performance indicates potential clinical utility in identifying patients at risk of hypoglycaemia during their inpatient stay, which could lead to improved patient management and outcomes.
Internal validation was assessed using bootstrapping, in which sample datasets the same size as the original dataset are repeatedly resampled, with replacement, and in which model variables are re-estimated and averaged over the samples [21] ; this identifies any shrinkage necessary to reduce model over-optimism caused by overfitting. Missing data were handled using a chained multiple imputation technique with predictive mean matching. Bootstrapped results from each of the imputed datasets were combined using Rubin's rule. In sensitivity analysis, missing values were replaced by values in the normal range for the given clinical pathology test. Model calibration was assessed by plotting predicted probability of hypoglycaemia against observed probability. The significance level was set at 5% and all analyses were implemented in STATA 13.0.
Results

Flow chart
From a total of 106 580 patients admitted to our institution during 2014, 57 922 admissions were eligible (emergency or elective admissions) and, of those, 9584 admissions were in patients with diabetes. Hypoglycaemia occurred in 1327 (13.8%) admissions with diabetes, while the remaining 8257 (86.2%) did not have a hypoglycaemic event. A flow chart summarizing the selection process along with reasons for exclusion is shown in Fig. 1 .
A total of 6187 unique patients made up the 9584 admissions included in the analysis. Of the 1792 patients who contributed two or more admissions, 664 experienced a hypoglycaemic episode; none of these 664 patients had a hypoglycaemic episode in more than one admission.
Baseline characteristics
A summary of the differences in the baseline demographics and medication history in the study cohort is shown in Tables 1 and 2 . Patients in the hypoglycaemia group were older, were more deprived, had more comorbidities and were more likely to belong to an ethnic minority group compared to the group without hypoglycaemia. Insulin use and sulfonylureas were also proportionally more common in the hypoglycaemia group (Table 2) . A summary of the differences in baseline laboratory measurements is shown in Table 3 . Patients in the hypoglycaemia group were more likely to have elevated inflammation markers [C-reactive protein (CRP) levels], electrolyte disturbances or anaemia. Table S3 .
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Final model
Using a prespecified variable selection strategy, younger age categories, female gender, hyperkalaemia, an elevated neutrophil count and anaemia were not found to be significant predictors of hypoglycaemia in the multivariable logistic regression. Age >75 years, insulin and sulfonylurea therapy, black and Asian ethnicity, emergency admissions, lower estimated GFR (eGFR), higher CRP level, hyponatraemia (<125 mmol/l) and hypo-albuminaemia were the strongest predictors of hypoglycaemia in patients with diabetes mellitus admitted in the general ward. The final model (prior to bootstrapping) is shown in Table 4 .
In sensitivity analysis, we used multilevel modelling (xtlogit) to allow for any possible correlation between multiple admissions for an individual patient; this made very little difference to the model variables.
Model performance and internal validity
Receiver-operating curve analysis showed that the AUC was 0.733 (95% CI 0.719 to 0.747; Fig. 2 ). The threshold chosen to maximize both sensitivity and specificity was 0.15 predicted probability of hypoglycaemia, with the corresponding values being 59.3% and 73.7%, respectively. At this threshold, the positive predictive value was 26.6% and the negative predictive value was 91.8%. A confusion matrix describing model performance is shown in Fig. 3 . The model was internally validated by bootstrapping; model coefficients were unchanged and test statistics were similar to the primary model, indicating no evidence of overfitting: AUC 0.731 (95% CI 0.717 to 0.746), sensitivity 59.3%, specificity (Fig. 4 ) suggested that the model calibration was good (i.e. predicted probabilities of hypoglycaemia were similar to observed probabilities). In sensitivity analysis, missing clinical pathology test results were replaced with values in the normal range (Table S2) . This had little effect on the model performance: AUC 0.735 (95% CI 0.721 to 0.749), sensitivity 60.4%, specificity 73.4%, positive predictive value 26.8% and negative predictive value 92.0%.
Discussion
In this retrospective analysis of all diabetic admissions, we found that the occurrence of inpatient hypoglycaemia could be predicted by a combined model taking into account background medication (type of insulin, use of sulfonylureas), ethnicity (black and Asian), age (≥75 years old), type of admissions (emergency) and laboratory measurements (eGFR, CRP, sodium and albumin levels).
Considering that inpatient hypoglycaemia is significantly associated with inpatient mortality and increased length of hospital stay [10, 11] and that real-time-generated alerts using a validated computerized predictive algorithm may significantly reduce its occurrence [16] , the findings of the present study could provide a robustly validated basis to improve inpatient safety and outcomes. Importantly, this study also showed that the inclusion of routine biochemical data (such as CRP, albumin, eGFR and sodium), available at the time of admission, could add prognostic value to demographic and medication history, thus providing a more holistic and optimized approach to the prediction of hypoglycaemic events.
The present study should nevertheless be interpreted in the context of its limitations. First, external validity, that is assessing the model in a different environment on a different population, would be a prerequisite before recommending its adoption in clinical practice. Moreover, the extent of missing data with regard to HbA 1c prevented the plausible exploration of tight vs poor glycaemic control as a predictor of hypoglycaemia. The study used routinely collected observational data, and therefore there may be unobserved confounding for which it was not possible to make adjustments in the analysis; however, this does not vitiate the utility of the model or the observed association between the predictor variables and the outcome.
Taking the above into consideration and using the largest dataset of diabetic admissions to date, we suggest that the occurrence of inpatient hypoglycaemia may be predicted by a combined model using background medication ethnicity, age, type of admission and routine laboratory measurements as independent predictors. The predictive performance of the constructed model indicates potential clinical utility for identifying patients at high risk of inpatient hypoglycaemia. 
Supporting Information
Additional Supporting Information may be found in the online version of this article: 
